Amplifon stock forecast: Third-party price targets
Amplifon is an Italian hearing-care group listed on the Borsa Italiana, operating across Europe and other regions, with its share price influenced by company performance, sector trends, and broader market conditions. Explore third-party AMP price targets and technical analysis.
Amplifon S.P.A. (AMP) is trading around €13.86 in intraday European trade on 22 January 2026 as of 12:04pm UTC, moving within a session range of approximately €13.42–€13.92 on Capital.com’s EUR-denominated stock CFD feed. Past performance is not a reliable indicator of future results.
Recent trading takes place amid company-specific news after Amplifon reported third-quarter 2025 revenues of about €563.3 million, up 2.4% at constant exchange rates, and nine-month 2025 revenues of roughly €1,743.8 million, an increase of 1.8% at constant exchange rates versus the prior year (MarketScreener, 29 October 2025). The stock is also trading following the company’s 22 January 2026 announcement that it has been admitted to the Italian Revenue Agency’s cooperative compliance programme, which focuses on enhanced tax transparency and ongoing dialogue with the authority (Amplifion, 22 January 2026).
Amplifon stock forecast 2026–2030: Third-party price targets
As of 22 January 2026, third-party Amplifon stock predictions present a range of 12-month fair-value views based on earnings expectations, competitive dynamics, and broader healthcare demand. These third-party projections are illustrative in nature and may differ from live market pricing on Capital.com’s CFD platform.
Investing.com (consensus screen)
The consensus tool on Investing.com shows an average 12-month price target of about €17.20 for Amplifon, with a high estimate of €23 and a low estimate of €14 across 16 analysts and subsequently updated through December 2025. The service describes a 'Buy' skew in recommendations and cites upside potential versus the prevailing share price, as analysts factor in expected earnings growth and sector conditions (Investing.com, 22 January 2026).
Fintel (aggregated broker target)
Fintel reports that the average AMP stock forecast stands at about €21.03 per share, revised down from a previous €25.90 in July 2025, with individual forecasts ranging between roughly €16.11 and €29.40. The service states that this monthly-updated average reflects analysts’ fair-value estimates as models are adjusted amid evolving earnings expectations and macro conditions (Fintel, 19 January 2026).
Simply Wall St (future growth lens)
A future-growth review on Simply Wall St dated 16 January 2026 notes that analysts’ central 12-month target for Amplifon is around €20.93, following recent estimate revisions after earnings updates. The platform cites assumptions of mid-single-digit revenue growth and mid-teens earnings growth per year as key inputs behind its discounted cash-flow-based fair-value range.
Simply Wall St (valuation spotlight)
In a January 2026 valuation article, Simply Wall St highlights several fair-value estimates suggesting Amplifon’s intrinsic value could be materially above the prevailing share price, though exact targets differ by methodology. The piece notes that these estimates rely on scenarios for sustained global demand for hearing solutions and margin improvement amid the company’s expansion strategy, which may not fully account for near-term execution or macro risks (Simply Wall St, 21 January 2026).
MarketScreener (consensus snapshot)
A consensus page on MarketScreener shows an average target price of approximately €29.04 for Amplifon, with a high estimate near €34 and a low around €22 across 16 analysts. The site describes the mean recommendation as 'Outperform,' amid expectations for earnings recovery and continued international expansion in the medical equipment and distribution segment (MarketScreener, 9 January 2026).
Predictions and third-party forecasts are inherently uncertain, as they cannot fully account for unexpected market developments. Past performance is not a reliable indicator of future results.
AMP stock price: Technical overview
The AMP stock price is trading around €13.86 as of 12:04pm UTC on 22 January 2026, holding slightly above the classic pivot near €13.67 on the latest daily setup. The short-dated simple moving averages form a tight cluster, with the 20/50/100/200-day SMAs at roughly €13.68 / €13.62 / €14.26 / €16.38, leaving price above the short-term band but still below longer-term trend markers. The 14-day RSI sits near 53.6 in mid-range territory, while an ADX reading around 15.2 points to a weak underlying trend rather than a strong directional phase.
On the topside, the immediate reference is classic resistance R1 around €14.28, and a sustained daily close above that area would place the higher pivot near €14.81 into focus, with the €15 level acting as a broader psychological reference. On pullbacks, the classic pivot at about €13.67 aligns as initial support, followed by the lower support band near S1 at €13.14. A clearer break below this zone could expose deeper downside levels, depending on broader market conditions (TradingView, 22 January 2026).
This technical analysis is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any instrument.
Amplifon share price history (2024–2026)
AMP’s stock price has undergone a marked reset over the past two years, moving from the high-€20s and low-€30s in early 2024 to the mid-teens and then low-€10s by January 2026. The stock closed at €29.88 on 24 January 2024 and traded mostly in the €30–€35 range through mid-2024, before easing lower in the second half of the year and finishing 2024 at €24.88 on 30 December.
In 2025, the share price initially moved higher, trading above €34 in June after spending time around the €26–€27 area in February, but then reversed. By late July it was trading near €20.20, and the decline accelerated into the autumn, with prices near €15 in September and around €14–€15 in October. By 22 January 2026, Amplifon was trading near €13.92, leaving it materially below its levels two years earlier and well under the peaks seen in mid-2024.
Past performance is not a reliable indicator of future results.
Amplifon (AMP): Capital.com analyst view
Amplifon’s share price over the past two years has shifted from trading near €30–€35 in early 2024 to the mid-€10s and then low-€10s into January 2026, with the stock closing at €13.92 on 22 January 2026. This pullback has occurred alongside modest revenue growth and ongoing profitability at group level, with Amplifon reporting recurring EBITDA of €568 million in 2024, up 4.8% year on year, and consolidated revenues of about €1,180.5 million in the first half of 2025, a 1.6% increase at constant exchange rates despite a softer global hearing-care market. While that operational profile may be viewed as supportive for longer-term fundamentals, weaker trading conditions and guidance adjustments during 2025, including a reduced revenue growth outlook and margin pressure, illustrate how earnings sensitivity and macro headwinds can weigh on the share price.
Recent headlines have centred on both operating performance and governance developments, which can influence sentiment in different ways. Amplifon highlighted an improvement in organic growth trends and above-market performance in parts of its network in the third quarter of 2025, but also reported lower adjusted EBITDA and acknowledged that some key markets, such as the US, were growing below historical rates. This leaves scope for both cautious optimism and restraint when assessing demand conditions. At the same time, the company’s admission to the Italian Revenue Agency’s cooperative compliance programme in January 2026 underscores an emphasis on tax governance and transparency, which may be viewed positively by some market participants.
Summary – Amplifon 2026
- Amplifon (AMP) is quoted on Capital.com as a EUR-denominated stock CFD, last trading near €13.86–€13.92 in late January 2026 after an intraday range roughly between €13.42 and €13.92.
- Over the past two years, the share price has moved from the high-€20s and low-€30s in early 2024 to the low-€20s and then mid- to high-€10s during 2025, before sliding into the low-€10s by January 2026.
- Daily data for 2025 point to a pronounced downtrend, with the price trading above €34 in June, around €20 in July, and then easing through the mid-€10s in the autumn to finish the year near €13.8–€14.0.
- Short-term technical indicators place AMP slightly above its near-term moving-average band, with the 20/50/100/200-day simple MAs clustered around €13.68 / €13.62 / €14.26 / €16.38 and RSI(14) near 53.6, consistent with a weak, range-bound trend.
- Classic daily pivot levels highlight initial resistance near €14.28 and support around €13.67, framing the near-term trading range monitored by some short-term technical traders.
- Company updates across 2024–2025 point to modest revenue growth and solid absolute EBITDA generation, alongside margin pressure and guidance adjustments, which have coincided with the share’s decline through 2025.
Past performance is not a reliable indicator of future results.
FAQ
Who owns the most Amplifon stock?
Amplifon’s shareholder base includes a mix of institutional investors, long-term strategic holders, and free-float market participants. The founding family, through holding vehicles, has historically retained a significant stake, while international asset managers and pension funds also feature among disclosed shareholders. Ownership levels can change over time due to portfolio rebalancing, corporate actions, or market conditions, meaning publicly available filings and regulatory disclosures remain the most reliable source of current ownership information.
What is the five-year Amplifon share price forecast?
There is no single, agreed five-year AMP stock forecast. Most publicly available analyst projections focus on 12-month horizons and are revised regularly as new financial results, macroeconomic data, and sector trends emerge. Longer-term views tend to rely on assumptions around revenue growth, margins, competitive positioning, and healthcare demand, which may change over time. As a result, longer-range forecasts are inherently uncertain and should be interpreted with caution.
Is Amplifon a good stock to buy?
Whether Amplifon is a 'good' stock depends on individual objectives, time horizons, and risk tolerance. Some market participants focus on the company’s global footprint and the recurring nature of hearing-care demand, while others point to earnings sensitivity, margin pressure, and broader economic headwinds. Published analysis reflects a range of perspectives rather than a single conclusion. This information is not investment advice, and assessing suitability typically involves independent research or professional guidance.
Could Amplifon stock go up or down?
Like all listed equities, Amplifon’s share price can move both higher and lower. Price movements may reflect company earnings, guidance updates, sector trends, regulatory developments, or changes in broader market sentiment. Short-term fluctuations can also be influenced by technical factors and overall risk appetite in European equities. Past price behaviour does not predict future performance, and volatility means outcomes can differ across timeframes.
Should I invest in Amplifon stock?
Deciding whether to invest in Amplifon involves weighing potential returns against the risk of loss. Factors such as financial performance, balance-sheet strength, competitive dynamics, and macroeconomic conditions may all influence outcomes. This article provides contextual market information rather than personalised recommendations. Investment decisions are specific to individual circumstances, and some investors may choose to seek independent research or regulated financial advice before taking action.
Can I trade Amplifon CFDs on Capital.com?
Yes, you can trade Amplifon CFDs on Capital.com. Trading share CFDs lets you speculate on price movements without owning the underlying asset and to take long or short positions. However, contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses. You should ensure you understand how CFD trading works, assess your risk tolerance, and recognise that losses can occur quickly.